Background Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is an
established treatment option for many malignant and non‐malignant disorders. In the past …

For over 30 years, stem cells have been used in the replenishment of blood and immune
systems damaged by the cancer cells or during treatment of cancer by chemotherapy or …

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the
Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine …

It is still under debate whether bone marrow (BM) or peripheral blood (PB) should be the
preferred stem cell source in adult patients undergoing allogeneic stem cell transplantation …

Human umbilical cord blood (HUCB) is now considered a valuable source for stem cell‐
based therapies. HUCB cells are enriched for stem cells that have the potential to initiate …

Haemopoietic stem cell therapy is an increasingly adopted procedure in the treatment of
patients with malignant lymphoma. In this retrospective analysis, we evaluated 262 patients …

Allogeneic transplantation: peripheral blood vs. bone marrow : Current Opinion in Oncology
Allogeneic transplantation: peripheral blood vs. bone marrow : Current Opinion in Oncology …

Hematopoietic stem cell transplant (HSCT) is a standard treatment for many hematological
malignancies. Three different sources of stem cells, namely bone marrow (BM), peripheral …

Mobilized peripheral blood is increasingly used as the source of hematopoietic stem cells for
allogeneic transplantation, currently the only curative approach for sickle cell anemia …

OBJECTIVE: Some phenotypic and functional properties of lymphocytes from bone marrow
or peripheral blood stem cell donors were compared in a randomized study. MATERIALS …